Lord, Abbett & Co. LLC Bridge Bio Pharma, Inc. Transaction History

Lord, Abbett & Co. LLC

$30.7 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 07, 2024	SELL	$27.35 - $40.45 $8.03 Million - $11.9 Million	-293,688 Reduced 9.48%	2,804,394 $86.7 Million
Q1 2024 May 09, 2024	SELL	$27.35 - $40.45 $8.03 Million - $11.9 Million	-293,688 Reduced 9.48%	2,804,394 $86.7 Million
Q4 2023 Oct 07, 2024	BUY	$24.02 - $43.89 $55.3 Million - $101 Million	2,303,681 Added 289.99%	3,098,082 $125 Million
Q4 2023 Feb 12, 2024	BUY	$24.02 - $43.89 $55.3 Million - $101 Million	2,303,681 Added 289.99%	3,098,082 $125 Million
Q3 2023 Oct 07, 2024	BUY	$16.89 - $35.01 $13.4 Million - $27.8 Million	794,401 New	794,401 $20.9 Million
Q3 2023 Nov 13, 2023	BUY	$16.89 - $35.01 $13.4 Million - $27.8 Million	794,401 New	794,401 $20.9 Million
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $9.07 Million - $42.6 Million	-796,668 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$46.87 - $64.24 $1.19 Million - $1.63 Million	-25,350 Reduced 3.08%	796,668 $37.3 Million
Q2 2021 Aug 11, 2021	SELL	$46.47 - $63.93 $19 Million - $26.1 Million	-408,867 Reduced 33.22%	822,018 $50.1 Million
Q1 2021 May 11, 2021	BUY	$55.47 - $72.35 $8.7 Million - $11.4 Million	156,919 Added 14.61%	1,230,885 $75.8 Million
Q4 2020 Feb 09, 2021	BUY	$38.38 - $71.11 $17.6 Million - $32.7 Million	459,242 Added 74.71%	1,073,966 $76.4 Million
Q3 2020 Nov 12, 2020	SELL	$27.2 - $42.19 $8.6 Million - $13.3 Million	-316,009 Reduced 33.95%	614,724 $23.1 Million
Q2 2020 Aug 14, 2020	SELL	$22.22 - $35.69 $1.3 Million - $2.09 Million	-58,534 Reduced 5.92%	930,733 $30.4 Million
Q1 2020 May 14, 2020	BUY	$16.11 - $36.23 $484,637 - $1.09 Million	30,083 Added 3.14%	989,267 $28.7 Million
Q4 2019 Feb 14, 2020	BUY	$17.96 - $46.63 $2.84 Million - $7.39 Million	158,380 Added 19.78%	959,184 $33.6 Million
Q3 2019 Nov 14, 2019	BUY	$20.13 - $32.38 $6.19 Million - $9.96 Million	307,462 Added 62.32%	800,804 $17.2 Million
Q2 2019 Aug 14, 2019	BUY	$26.97 - $27.55 $13.3 Million - $13.6 Million	493,342 New	493,342 $13.3 Million

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

Kohlberg Kravis Roberts & Co. L.P. New York, NY

25.3M
Shares

$668 Million
35.94% of portfolio
Viking Global Investors LP

25.1M
Shares

$664 Million
2.47% of portfolio
Vanguard Group Inc Valley Forge, PA

14.2M
Shares

$375 Million
0.01% of portfolio
Black Rock Inc. New York, NY

12.4M
Shares

$329 Million
0.01% of portfolio
Aisling Capital Management LP New York, NY

6.07M
Shares

$160 Million
63.58% of portfolio

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.92B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account